Table 2.
Univariate and multivariate analysis of overall survival in PDAC patients (n = 134)
| Variables | Characteristics | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | ||
| Age | <60 (ref) | ||||||
| ≥60 | 0.920 | 0.615–1.378 | 0.687 | ||||
| Gender | Female (ref) | ||||||
| Male | 0.948 | 0.629–1.428 | 0.797 | ||||
| Differentiation | Well (ref) | ||||||
| Moderate | 0.951 | 0.537–1.685 | 0.863 | ||||
| Poor | 1.701 | 0.868–3.335 | 0.122 | ||||
| TNM stage | I (ref) | ||||||
| II | 1.491 | 0.853–2.606 | 0.161 | 0.994 | 0.531–1.859 | 0.984 | |
| III | 2.596 | 1.458–4.621 | 0.001** | 1.823 | 0.963–3.449 | 0.065 | |
| IV | 3.976 | 2.064–7.659 | <0.001*** | 2.252 | 1.100–4.609 | 0.026* | |
| Lymph node metastasis | Negative (ref) | ||||||
| Positive | 2.601 | 1.640–4.123 | <0.001*** | 1.950 | 1.193–3.187 | 0.008** | |
| Perineural invasion | Negative (ref) | ||||||
| Positive | 1.543 | 0.976–2.438 | 0.063 | ||||
| VCAM-1 expression | Low (ref) | ||||||
| Moderate | 3.680 | 1.965–6.891 | <0.001*** | 2.332 | 1.152–4.772 | 0.019* | |
| High | 5.448 | 2.930–10.130 | <0.001*** | 2.948 | 1.445–6.014 | 0.003** | |
| CCL18 expression | Low (ref) | ||||||
| Moderate | 2.585 | 1.340–4.985 | 0.005** | 1.721 | 0.839–3.532 | 0.139 | |
| High | 4.523 | 2.296–8.910 | <0.001*** | 2.267 | 1.080–4.762 | 0.031* | |
HR hazard ratio; 95% CI 95% confidence interval; TNM tumor node metastasis; T stage tumor stage; ref reference
Cox regression analysis, *p < 0.05, **p < 0.01, ***p < 0.001